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Innate Immunity Stimulates
Permeability Barrier Homeostasis
Kenneth R. Feingold1
A key function of the skin is to provide a permeability barrier to restrict the
movement of water, electrolytes, and other small molecules between the outside
environment and the internal milieu. Following disruption of the permeability
barrier, there is a rapid restoration of barrier function, and one of the key
signals initiating this repair response is a decrease in the concentration of
calcium in the outer epidermis. In this issue, Borkowski et al. present evidence
showing that activation of Toll receptor 3 by double-stranded RNA may be
another pathway for activation of permeability barrier repair. These results
provide further evidence for a link between innate immunity and the permeability
barrier.
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An important function of the skin is to
form a barrier between an outside hos-
tile environment and the internal milieu.
One key barrier function is to restrict
the movement of water, electrolytes, and
other small compounds, that is, the
permeability barrier. Without a compe-
tent permeability barrier, life outside of
the sea would be impossible. Recent
studies have linked abnormalities in
permeability barrier function to the
development and progression of com-
mon skin disorders, including atopic
dermatitis and psoriasis (Wolf and
Wolf, 2012; Wolf et al., 2012).
The permeability barrier is mediated
by lipid-enriched lamellar membranes
located in the extracellular spaces of
the stratum corneum (Feingold, 2007).
The membranes contain ceramides,
cholesterol, and free fatty acids predomi-
nantly. These lipids are delivered to the
stratum corneum through the exocytosis
of lamellar bodies from stratum gra-
nulosum cells (Feingold, 2007). In turn,
the lamellar bodies contain glucosylcer-
amides, sphingomyelin, phospholipids,
and cholesterol. To form functional
lamellar membranes, the glucosylcera-
mides and sphingomyelin are converted
to ceramides, a process catalyzed by
the enzymes beta-glucocerebrosidase
and acid sphingomyelinase, and the
phospholipids are converted to free
fatty acids, a process catalyzed by
PLA2 (Feingold, 2007). The synthesis of
lamellar bodies by keratinocytes requires
a sufficient pool of cholesterol, sphing-
olipids, and phospholipids. Fatty acids
are required for the synthesis of
phospholipids and sphingolipids, and
they are derived from either de novo
synthesis by keratinocytes and/or uptake
of exogenous fatty acids by keratinocytes
(Feingold, 2007). Cholesterol may also
be synthesized in keratinocytes and/or
transported into keratinocytes by several
uptake pathways (Feingold, 2007). The
mechanism by which phospholipids
and cholesterol are incorporated into
lamellar bodies is not known, but
recent studies have demonstrated that
the transport of glucosylceramides into
lamellar bodies is mediated by ABCA12
(Feingold, 2007).
Following disruption of the perme-
ability barrier, there is a rapid restora-
tion of barrier function (Feingold, 2007).
A number of responses occur in the
underlying epidermis that facilitate this
repair process, including: (1) an almost
immediate secretion of a pre-formed
pool of lamellar bodies, (2) increased
lipid synthesis, (3) an increase in
lipoprotein receptors and fatty acid
transport proteins that facilitate the
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uptake of exogenous lipids, (4) increased
expression of enzymes required for
extracellular processing of lipids, and
(5) increased formation of new lamellar
bodies (Feingold, 2007). One of the key
signals that activates this repair program
is a change in the level of calcium and
other ions in the stratum granulosum
(Feingold, 2007; Feingold and Denda,
2012). Under normal conditions, there
are high concentrations of calcium in
the stratum granulosum. Following
permeability barrier disruption, the cal-
cium concentration decreases markedly,
and barrier repair ensues. If the decrease
in the calcium gradient is inhibited,
barrier repair is also inhibited. Con-
versely, if one lowers the concentration
of calcium in the outer epidermis
without disrupting the barrier, the
secretion and formation of lamellar
bodies is stimulated. Thus, the concen-
tration of calcium in the stratum
granulosum controls the initiation
and/or inhibition of barrier formation
(Feingold, 2007; Feingold and Denda,
2012).
In this issue, Borkowski et al. (2013)
describe another potential mechanism
for the activation of permeability barrier
repair. Epidermal injury leads to an
increase in double-stranded RNA
(dsRNA) that can bind to Toll receptor
3 (TLR3) (Lai et al., 2009; Bernard et al.,
2012). Toll receptors are well known to
recognize pathogen-associated molecular
patterns and TLR3 recognizes dsRNA,
which is a key pathway by which the
host recognizes and combats viral
infections (Aderem and Ulevitch,
2000). Borkowski et al demonstrate that
treatment of keratinocytes with dsRNA
stimulates the expression of several
genes that have key roles in permea-
bility barrier repair. Specifically, they de-
monstrate the upregulation of ABCA12,
glucocerebrosidase, acid sphingomyeli-
nase, serine palmotyltranferase (the first
enzyme in the synthesis of ceramides),
glucosylceramide synthase, and trans-
glutaminase 1. They further show that
many of these changes induced by
dsRNA are mediated by TLR3 by
demonstrating that, when TLR3 is
knocked down using siRNA or the
intracellular signaling pathways for
TLR3 are blocked, the upregulation of
many of these proteins by dsRNA fails to
occur. Notably, the increase in enzymes
involved in ceramide and glucosyl-
ceramide synthesis is not inhibited,
indicating that recognition pathways in
addition to TLR3 may have important
roles. Furthermore, the authors show that
dsRNA treatment leads to an increase in
oil red O staining in keratinocytes, and
lipid analysis revealed an increase in
certain sphingolipids, without changes
in cholesterol. The marked increase in
oil red O staining is unlikely to be
accounted for by the relatively small
increase in sphingolipids. Unfortu-
nately, triglyceride levels were not
determined, but it is likely that an
increase in triglycerides could account
for the increase in oil red O staining.
Finally, and most importantly,
Borkowski et al. demonstrate that
treatment with dsRNA increases the
number of lamellar bodies in skin
constructs and that this increase is
dependent on TLR3. Taken together,
these results suggest that the increase in
dsRNA that occurs with epidermal tissue
injury could stimulate lamellar body
formation and permeability barrier
repair. These results suggest that
activation of innate immunity in the
epidermis stimulates permeability
barrier homeostasis. It should be
recognized that dsRNA and TLR3
activation appears to stimulate only
certain aspects of the permeability
barrier repair program. For example,
cholesterol and fatty acid synthesis do
not appear to be enhanced. Future
studies determining the ability of TLR3-
deficient mice to restore permeability
barrier function following barrier
perturbation will be required to
understand the role and significance of
the TLR3 signaling pathway more fully.
Whether the activation of other Toll
receptors or the nucleotide-binding
oligomerization domain-like receptor
(NLR) family of proteins stimulates
permeability barrier homeostasis also
needs to be addressed.
That there may be links between
innate immunity and the permeability
barrier should not be surprising. Provid-
ing both a permeability barrier and a
barrier to microorganisms are key func-
tions of the skin. Moreover, earlier
studies have shown that these functions
are linked. For example, disruption of
the permeability barrier has been shown
to increase the synthesis of anti-micro-
bial peptides, whereas the production of
anti-microbial peptides has been shown
to have an important role in the forma-
tion of the permeability barrier (Aberg
et al., 2008; Ahrens et al., 2011;
Rodriguez-Martin et al., 2011). Thus, it
is easy to visualize that the activation of
pathogen-associated molecular pattern
receptors (TLRs) by either microbial
products or endogenous compounds
could stimulate permeability barrier
formation. A competent permeability
barrier limits the ability of micro-
organisms and toxic products to enter
the host.
Finally, it should be recognized that
there is a link between activation of
TLRs and lipid metabolism that extends
beyond keratinocytes and the epidermis.
Our laboratory and others have shown
Clinical Implications
 A crucial function of the skin is to form a barrier between an outside
hostile environment and the internal milieu, and abnormalities in barrier
function are linked to common skin disorders, including atopic dermatitis
and psoriasis.
 The study by Borkowski et al. (this issue) suggests that an increase in
double-stranded RNA that occurs with epidermal tissue injury could, via
activation of the Toll receptor 3 signaling pathway, stimulate lamellar body
formation and permeability barrier repair.
 In combination with earlier studies, these results demonstrate additional
links among innate immunity, host defense, and permeability barrier
homeostasis.
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that LPS, a TLR4 activator, stimulates
cholesterol ester and triglyceride storage
in macrophages (Lopes-Virella et al.,
1987; Oiknine and Aviram, 1992;
Funk et al., 1993). When macrophages
were incubated with cholesterol ester-
rich lipoproteins, LPS-stimulated
cholesterol ester accumulated, whereas
in the absence of cholesterol ester-
enriched lipoproteins there was an
increase in triglyceride accumulation
(Lopes-Virella et al., 1987; Oiknine
and Aviram, 1992; Funk et al., 1993).
In the presence of triglyceride-enriched
lipoproteins or free fatty acids, the
increase in macrophage triglyceride
storage was markedly enhanced by LPS
(Funk et al., 1993; Feingold et al., 2010,
2012). Activation of TLR2 by zymosan
or TLR3 by dsRNA has also been shown
to increase lipid accumulation in
macrophages (Feingold et al., 2010,
2012). In addition, incubation of
bacteria with macrophages results in
lipid accumulation, which is
dependent on TLR signaling (Nicolaou
and Erridge, 2010; Nicolaou et al.,
2012). Finally, lipid-filled macrophages
have been observed during chronic
inflammatory conditions such as
parasitic infections and leprosy
(D’Avila et al., 2008; Mattos et al.,
2010; Nicolaou and Erridge, 2010).
This increase in lipid storage is thought
to have a role in the ability of
macrophages to fight infection. The
lipolysis of triglycerides has a key role
in macrophage phagocytosis and the
increase in fat droplets may have a
role in sequestering intracellular
microorganisms and preventing their
replication (Chandak et al., 2010). It is
also possible that the large quantities
of triglycerides or perhaps metabolic
products of triglycerides (for example,
free fatty acids) may be toxic to
microorganisms and have a role in
killing bacteria, viruses, or fungi (Drake
et al., 2008). Thus, one could speculate
that the stimulation of lipid metabolism
induced by TLR3 activation, leading
to an increase in lipids in keratino-
cytes, may have a role not only in
facilitating permeability barrier repair
but perhaps also in enhancing host
defense.
A very recent study has linked activa-
tion of TLR2 with skin barrier repair.
In TLR2 KO mice there is a delay in
the repair of the permeability barrier
(Kuo et al., 2013).
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